InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,304.80
(
0.47%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.44
(
0.02%
)
Bitcoin
61,801.14
(
0.31%
)

Replies to post #370532 on Elite Pharmaceuticals Inc (ELTP)

Replies to #370532 on Elite Pharmaceuticals Inc (ELTP)

ZetaReticuli

06/29/22 8:37 AM

#370535 RE: sharkey1 #370532

Hard to say because Sabril was already being hit by generic competition in 2021 which would imply there are other generic sales that were taking 20% of their market share. It certainly beefs up Elite's drug portfolio.